Paul Chapman on a hookworm vaccine
The Lancet Infectious Diseases in conversation with - Un podcast de The Lancet Group
Catégories:
Paul Chapman and colleagues presents the results of an innovative trial assessing the safety of vaccinating healthy volunteers with attenuated Necator americanus hookworm larvae. Read the full article:https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00153-5/fulltextContinue this conversation on social!Follow us today at...https://twitter.com/thelancethttps://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancetht...
